Bulat Pharmaceutical

Bulat Pharmaceutical is an Indian pharmaceutical company specializing in the development, manufacturing, and supply of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates. Founded in 2017 and headquartered in Gurugram, the company operates as a subsidiary of the Chinese firm Shandong Sihuan Pharma. Bulat Pharmaceutical offers a diverse portfolio of products across therapeutic areas including oncology, diabetes, cardiovascular diseases, and infectious diseases. Their core capabilities encompass API development, scale-up, and custom manufacturing (CDMO) services for both small molecules and peptides. The company serves a global clientele, providing critical components for drugs such as Linagliptin, Sacubitril, and various targeted cancer therapies. With a focus on quality and innovation, Bulat Pharmaceutical supports the pharmaceutical industry through the production of complex intermediates and specialty chemicals.